Abstract: The present invention is directed to tetrapeptides which inhibit farnesyl-protein transferase (FPTase) and the farnesylation of the oncogene protein Ras. The invention is further directed to a method of treating cancer with tetrapeptide inhibitors of farnesyl protein transferase, as well as pharmaceutical formulations useful for this method of treatment.
Type:
Grant
Filed:
June 2, 1995
Date of Patent:
August 26, 1997
Assignees:
Merck & Co. Inc., Istituto Di Ricerche Di Biologia Molecolare (IRBM)
Inventors:
Richardo Cortese, Jackson B. Gibbs, Antonello Pessi, Andrew Wallace